A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Clinical trial NCT07244705 · RECRUITING

Trial details

NCT number: NCT07244705
Sponsor: Anbogen Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer (Diagnosis)Colorectal Cancer Metastatic Colorectal Cancer (CRC)Immunotherapy

Start date: 2025-11-01
Primary completion: 2028-04-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.